Bigfoot Biomedical announces $45M Series C tranche, expands partnership with Abbott
Bigfoot has agreed to develop and commercialize new programs that will integrate with Abbott’s diabetes management platform.
Related Articles
Recording facial expressions with emotion-sensing eyeglasses
Steen Strand, CEO of Emteq Labs, discusses the company’s launch of Sense, emotion-sensing eyewear that collects real-world data on a wearer’s facial expressions and emotions…
Exclusive: American Heart Association Ventures invests in MDisrupt
The AHA and MDisrupt will also co-develop a platform to enable expert referrals and disseminate evidence-based science to healthcare technology innovators.
Owlet wins back compliance with NYSE continued listing standards
The company will be subject to a 12-month follow-up review period to assure that it does not fall below NYSE standards.
Applying AI use cases within hospitals
Dr. Zafar Chaudry, Seattle Children’s chief digital officer and chief AI and information officer, discusses the importance of effective change management during AI implementation –…
Springbok Analytics receives FDA 510(k) clearance for MuscleView
The AI-enabled technology measures musculoskeletal structures from an MRI scan.
Glooko scores $100M and appoints new CEO
The company will use the funds to accelerate its product expansion on a global scale.
Patient engagement platform RadiantGraph garners $11M
The Series A funding announcement comes less than a month after the company announced integration capabilities with AWS, Google Cloud, Databricks and Snowflake.
Suki secures $70M to enhance its AI ambient scribe offerings
The company will use the funds to expand its partnerships with Athena, Oracle Cerner, Epic and MEDITECH and enhance its offerings, Suki Assistant and Suki…
Stanford’s use of genAI tools
Shreya Shah, medical informatics director at Stanford Health Care, discusses the health system’s use of genAI for patient message replies and ambient AI scribes to…
MARAbio raises $15M for its blood test that detects autism and more
SPRY Therapeutics, an AI-enabled physical therapy platform, and Every Cure, an AI-powered biotech organization, also secured funds.